Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,755
Total Claims
$1.4M
Drug Cost
1,256
Beneficiaries
$1,146
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-89%
Opioid rate vs peers
0.2% vs 2.2% avg
-19%
Cost per patient vs peers
$1,146 vs $1,411 avg
+25%
Brand preference vs peers
13.3% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
31
Opioid Claims
$4,514
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,684 claims · $1.2M
Generic: 10,992 claims · $270K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 173 | $196K |
| Dapagliflozin Propanediol | 110 | $140K |
| Apixaban | 104 | $131K |
| Tirzepatide | 96 | $119K |
| Empagliflozin | 51 | $76K |
| Rivaroxaban | 36 | $34K |
| Sacubitril/Valsartan | 20 | $27K |
| Rosuvastatin Calcium | 1,403 | $27K |
| Semaglutide | 18 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $19K |
| Lurasidone Hcl | 12 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $16K |
| Mirabegron | 11 | $14K |
| Fluticasone/Vilanterol | 22 | $14K |
| Atorvastatin Calcium | 805 | $13K |
Prescribing Profile
Patient Profile
74
Avg Age
51%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data